IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY

被引：0

作者：

Dougados, M. ^{[1
]}

Lardy-Cleaud, A. ^{[2
]}

Desfleurs, E. ^{[3
]}

Claudepierre, P. ^{[4
]}

Goupille, P. ^{[5
]}

Ruyssen-Witrand, A. ^{[6
]}

Saraux, A. ^{[7
]}

Tournadre, A. ^{[8
]}

Wendling, D. ^{[9
]}

Lukas, C. ^{[10
,11
]}

机构：

[1] Hop Cochin, Assistance Publ Hop Paris, Dept Rheumatol, Paris, France

[2] RCTs Clin Res Org, Biostat, Lyon, France

[3] Novartis, Med Affairs, Rueil Malmaison, France

[4] Hop Henri Mondor, Assistance Publ Hop Paris, Dept Rheumatol, Creteil, France

[5] Univ Hosp Tours, Dept Rheumatol, Tours, France

[6] Univ Hosp Toulouse, Rheumatol Ctr, Toulouse, France

[7] Univ Hosp Brest, Dept Rheumatol, Brest, France

[8] Univ Hosp Clermont Ferrand, Dept Rheumatol, Clermont Ferrand, France

[9] Univ Hosp Besancon, Dept Rheumatol, Besancon, France

[10] Univ Hosp Montpellier, Dept Rheumatol, Montpellier, France

[11] Univ Hosp Montpellier, Dept Rheumatol, Montpellier, France

来源：

关键词：

Prognostic factors; Spondyloarthritis; Real-world evidence;

D O I：

10.1136/annrheumdis-2023-eular.2356

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS1123

引用

页码：888 / 889

页数：2